{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:37:44Z","timestamp":1793813864042,"version":"4.6.1"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>When the US varicella vaccination program was introduced in 1995, its impacts on the epidemiology of herpes zoster (HZ) were not precisely known. We used a large claims database to examine HZ incidence in the US during 1998\u20132019 among persons aged \u226530 years (the prevaccine cohort, born before 1990), and aged 1\u201329 years (includes the postvaccine cohort, born since 1990). We defined incident HZ as the first instance of an outpatient or emergency department (ED) claim with an HZ diagnostic code. Additionally, we examined the proportion of HZ visits among all ED visits as a complementary method to assess for healthcare-seeking artifacts in the findings. In persons aged \u226530 years (prevaccine cohort), we observed age-specific increases in HZ incidence during the earlier study years, with decelerations in later years, starting in 2007 with oldest age groups. Similar patterns were seen when we examined HZ visits as a proportion of all ED visits. For persons aged 1\u201329 years, age-specific HZ incidence increased early in the study period for the oldest age groups who were born prevaccine, but later declined in a stepwise pattern once each age group was comprised of persons born in the postvaccine period. Our results, corroborated with previously published studies, do not support prior modeling predictions that the varicella vaccination program would increase HZ incidence among adult cohorts who previously experienced varicella. Our findings also suggest that continued declines in age-specific HZ incidence as varicella-vaccinated cohorts age are likely.<\/jats:p>","DOI":"10.1093\/infdis\/jiac255","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T11:57:06Z","timestamp":1661342226000},"page":"S470-S477","source":"Crossref","is-referenced-by-count":35,"title":["The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States: Comparison of Birth Cohorts Preceding and Following Varicella Vaccination Program Launch"],"prefix":"10.1093","volume":"226","author":[{"given":"Jessica","family":"Leung","sequence":"first","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Dooling","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Marin","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara C","family":"Anderson","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Harpaz","sequence":"additional","affiliation":[{"name":"Harpaz-Herman Consultants , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"issue":"Suppl 2","key":"2022102100075491500_jiac255-B1","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2014United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"key":"2022102100075491500_jiac255-B2","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"key":"2022102100075491500_jiac255-B3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"key":"2022102100075491500_jiac255-B4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"},{"key":"2022102100075491500_jiac255-B5","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac221","article-title":"Monitoring varicella vaccine impact on varicella incidence in the United States: surveillance challenges and changing epidemiology, 1995\u20132019","author":"Marin","year":"2022","journal-title":"J Infect Dis"},{"key":"2022102100075491500_jiac255-B6","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac242","article-title":"Decline in severe varicella disease during the United States varicella vaccination program: hospitalizations and deaths, 1990\u20132019","author":"Marin","year":"2022","journal-title":"J Infect Dis"},{"key":"2022102100075491500_jiac255-B7","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac214","article-title":"Changing epidemiology of varicella outbreaks in the United States during the varicella vaccination program, 1995\u20132019","author":"Leung","year":"2022","journal-title":"J Infect Dis"},{"key":"2022102100075491500_jiac255-B8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jpids\/piv044","article-title":"Impact of the maturing varicella vaccination program on varicella and related outcomes in the United States: 1994\u20132012","volume":"5","author":"Leung","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2022102100075491500_jiac255-B9","doi-asserted-by":"crossref","first-page":"e20182917","DOI":"10.1542\/peds.2018-2917","article-title":"Incidence of herpes zoster among children: 2003\u20132014","volume":"144:","author":"Weinmann","year":"2019","journal-title":"Pediatrics"},{"key":"2022102100075491500_jiac255-B10","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1016\/j.vaccine.2020.05.006","article-title":"Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine","volume":"38","author":"Weinmann","year":"2020","journal-title":"Vaccine"},{"key":"2022102100075491500_jiac255-B11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14760584.2019.1646129","article-title":"Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States","volume":"18","author":"Harpaz","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"2022102100075491500_jiac255-B12","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"2022102100075491500_jiac255-B13","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1002\/jmv.10364","article-title":"Varicella in Americans from NHANES III: implications for control through routine immunization","volume":"70","author":"Kilgore","year":"2003","journal-title":"J Med Virol"},{"key":"2022102100075491500_jiac255-B14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciy953","article-title":"The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults","volume":"69","author":"Harpaz","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022102100075491500_jiac255-B15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciy954","article-title":"The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among children","volume":"69","author":"Harpaz","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022102100075491500_jiac255-B16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022102100075491500_jiac255-B17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-159-11-201312030-00006","article-title":"Examination of links between herpes zoster incidence and childhood varicella vaccination","volume":"159","author":"Hales","year":"2013","journal-title":"Ann Intern Med"},{"key":"2022102100075491500_jiac255-B18","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"2022102100075491500_jiac255-B19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing incidence of herpes zoster over a 60-year period from a population-based study","volume":"63","author":"Kawai","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022102100075491500_jiac255-B20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12879-016-1898-z","article-title":"Increasing incidence associated with herpes zoster infection in British Columbia, Canada","volume":"16","author":"Marra","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2022102100075491500_jiac255-B21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022102100075491500_jiac255-B22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"2022102100075491500_jiac255-B23","first-page":"995","article-title":"The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: updated evidence from observational databases, 1991\u20132016","volume":"70","author":"Wolfson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022102100075491500_jiac255-B24","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"2022102100075491500_jiac255-B25","first-page":"357","article-title":"Temporal trends in the annual population-based incidence of herpes zoster by age and gender: Manitoba, 1979\u20131998","volume":"15","author":"Law","year":"2004","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2022102100075491500_jiac255-B26","first-page":"1531","article-title":"A clinical study on herpes zoster during the last 10-year-period (1994\u20132003)","volume":"42","author":"Park","year":"2004","journal-title":"Korean J Dermatol"},{"key":"2022102100075491500_jiac255-B27","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S2468-2667(17)30234-7","article-title":"Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study","volume":"3","author":"Amirthalingam","year":"2018","journal-title":"Lancet Public Health"},{"issue":"Suppl 2","key":"2022102100075491500_jiac255-B28","first-page":"40","article-title":"Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America","volume":"14","author":"Ara\u00fajo","year":"2007","journal-title":"Herpes"},{"key":"2022102100075491500_jiac255-B29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12879-019-3691-2","article-title":"Herpes zoster incidence in Germany\u2014an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort","volume":"19","author":"Caputo","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2022102100075491500_jiac255-B30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/infdis\/jiab500","article-title":"No consistent evidence of decreased exposure to varicella-zoster virus among older adults in countries with universal varicella vaccination","volume":"225","author":"Carryn","year":"2022","journal-title":"J Infect Dis"},{"key":"2022102100075491500_jiac255-B31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1017\/S0950268818000444","article-title":"The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014","volume":"146","author":"Chan","year":"2018","journal-title":"Epidemiol Infect"},{"key":"2022102100075491500_jiac255-B32","first-page":"138","article-title":"Herpes zoster in the Czech Republic\u2014epidemiology and clinical manifestations","volume":"59","author":"Smetana","year":"2010","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"2022102100075491500_jiac255-B33","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","article-title":"Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program","volume":"29","author":"Tanuseputro","year":"2011","journal-title":"Vaccine"},{"key":"2022102100075491500_jiac255-B34","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/jmv.21599","article-title":"Epidemiology of herpes zoster and its relationship to varicella in Japan: a 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture","volume":"81","author":"Toyama","year":"2009","journal-title":"J Med Virol"},{"key":"2022102100075491500_jiac255-B35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0956797614563765","article-title":"Social structure, infectious diseases, disasters, secularism, and cultural change in America","volume":"26","author":"Grossmann","year":"2015","journal-title":"Psychol Sci"},{"key":"2022102100075491500_jiac255-B36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12916-017-0983-5","article-title":"Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany\u2014a mathematical modelling study","volume":"16","author":"Horn","year":"2018","journal-title":"BMC Med"},{"key":"2022102100075491500_jiac255-B37","first-page":"20142509","article-title":"The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study","volume":"282","author":"Marziano","year":"2015","journal-title":"Proc Biol Sci"},{"key":"2022102100075491500_jiac255-B38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12916-018-1094-7","article-title":"The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study","volume":"16","author":"Melegaro","year":"2018","journal-title":"BMC Med"},{"key":"2022102100075491500_jiac255-B39","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2022102100075491500_jiac255-B40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2022102100075491500_jiac255-B41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"2022102100075491500_jiac255-B42","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.41.20926","article-title":"Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012","volume":"19","author":"Kelly","year":"2014","journal-title":"Euro Surveill"},{"key":"2022102100075491500_jiac255-B43","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/14760584.2018.1538801","article-title":"Understanding the role of exogenous boosting in modeling varicella vaccination","volume":"17","author":"Talbird","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"2022102100075491500_jiac255-B44","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine"},{"key":"2022102100075491500_jiac255-B45","doi-asserted-by":"crossref","first-page":"l6987","DOI":"10.1136\/bmj.l6987","article-title":"Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data","volume":"368:","author":"Forbes","year":"2020","journal-title":"BMJ"},{"key":"2022102100075491500_jiac255-B46","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41598-017-01024-8","article-title":"Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox","volume":"7","author":"Ogunjimi","year":"2017","journal-title":"Sci Rep"},{"key":"2022102100075491500_jiac255-B47","article-title":"Performance of zoster vaccine live (Zostavax): a systematic review of 12 years of experimental and observational evidence [abstract 1337]","author":"Dooling"},{"key":"2022102100075491500_jiac255-B48","doi-asserted-by":"crossref","first-page":"e037458","DOI":"10.1136\/bmjopen-2020-037458","article-title":"Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study","volume":"10","author":"Andrews","year":"2020","journal-title":"BMJ Open"},{"key":"2022102100075491500_jiac255-B49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jinf.2022.01.011","article-title":"Impact of a national immunisation program on herpes zoster incidence in Australia","volume":"84","author":"Lin","year":"2022","journal-title":"J Infect"},{"key":"2022102100075491500_jiac255-B50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/cid\/ciaa014","article-title":"Impact of a publicly funded herpes zoster immunization program on the burden of disease in Ontario, Canada: a population-based study","volume":"72","author":"Martins","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022102100075491500_jiac255-B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"2022102100075491500_jiac255-B52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jdermsci.2021.10.007","article-title":"Effect of universal varicella vaccination and behavioral changes against coronavirus disease 2019 pandemic on the incidence of herpes zoster","volume":"104","author":"Shiraki","year":"2021","journal-title":"J Dermatol Sci"},{"key":"2022102100075491500_jiac255-B53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12879-017-2185-3","article-title":"Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia","volume":"17","author":"Friesen","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2022102100075491500_jiac255-B54","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac337","article-title":"Celebrating 25 years of varicella vaccination coverage for children and adolescents in the United States: a success story","author":"Elam-Evans","year":"2022","journal-title":"J Infect Dis"},{"key":"2022102100075491500_jiac255-B55","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2105\/AJPH.2009.160002","article-title":"Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination","volume":"100","author":"Donahue","year":"2010","journal-title":"Am J Public Health"},{"key":"2022102100075491500_jiac255-B56","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/cid\/ciw854","article-title":"Effectiveness and duration of protection provided by the live-attenuated herpes zoster vaccine in the Medicare population ages 65 years and older","volume":"64","author":"Izurieta","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022102100075491500_jiac255-B57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"key":"2022102100075491500_jiac255-B58","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1467-842X.2005.tb00248.x","article-title":"Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia","volume":"29","author":"Gidding","year":"2005","journal-title":"Aust N Z J Public Health"},{"key":"2022102100075491500_jiac255-B59","first-page":"1766","article-title":"Current and future effects of varicella and herpes zoster vaccination in Germany\u2014insights from a mathematical model in a country with universal varicella vaccination","volume":"12","author":"Horn","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2022102100075491500_jiac255-B60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0950268809990768","article-title":"Modelling the impact of varicella vaccination on varicella and zoster","volume":"138","author":"Karhunen","year":"2010","journal-title":"Epidemiol Infect"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/Supplement_4\/S470\/46582596\/jiac255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/Supplement_4\/S470\/46582596\/jiac255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T20:11:18Z","timestamp":1666296678000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/226\/Supplement_4\/S470\/6764830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":60,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2022,10,21]]},"published-print":{"date-parts":[[2022,10,21]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiac255","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,10,21]]}}}